Skip to main content
logo
Knight Therapeutics Inc. (TSX:GUD)
Canada flag Canada · Delayed Price · Currency is CAD
7.65
-0.02 (-0.26%)
Apr 17, 2026, 4:00 PM EST

Knight Therapeutics Income Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
450.09371.3328.2293.56243.48
Revenue Growth (YoY)
21.22%13.13%11.80%20.57%22.03%
Cost of Revenue
249.86196.9175.55155.5128.07
Gross Profit
200.23174.41152.65138.06115.41
Selling, General & Admin
124.1199.3583.6988.6274.38
Depreciation & Amortization Expenses
49.4944.3645.0451.7441.18
Research & Development
28.9823.317.5514.7612.69
Other Operating Expenses
--9.2623.98-
Total Operating Expenses
202.58167.01155.54179.11128.24
Operating Income
-2.357.4-2.89-41.04-12.83
Interest Income
6.2110.4112.5810.637.38
Interest Expense
-10.42-9.22-12.49-6.6-3.62
Other Non-Operating Income (Expense)
-0.14-6.53-19.19-6.9515.76
Total Non-Operating Income (Expense)
-4.35-5.35-19.1-2.9219.52
Pretax Income
-6.72.05-21.99-43.966.69
Net Income
-6.72.05-21.99-43.966.69
Net Income to Common
-6.72.05-21.99-43.966.69
Net Income Growth
-----83.97%
Shares Outstanding (Basic)
100101107115124
Shares Outstanding (Diluted)
100101107115125
Shares Change (YoY)
-1.84%-5.61%-6.46%-7.74%-5.65%
EPS (Basic)
-0.050.04-0.16-0.260.13
EPS (Diluted)
-0.050.04-0.16-0.260.13
EPS Growth
-----59.38%
Shares Outstanding
99.18100.03101.17112.21117.78
Free Cash Flow
67.0533.8134.9942.1240.79
Free Cash Flow Growth
98.30%-3.37%-16.92%3.26%-
Free Cash Flow Per Share
0.670.330.330.370.33
Gross Margin
44.49%46.97%46.51%47.03%47.40%
Operating Margin
-0.52%1.99%-0.88%-13.98%-5.27%
Profit Margin
-1.49%0.55%-6.70%-14.97%2.75%
FCF Margin
14.90%9.11%10.66%14.35%16.75%
EBITDA
54.2260.5147.5121.5835.08
EBITDA Margin
12.05%16.30%14.48%7.35%14.41%
EBIT
-2.357.4-2.89-41.04-12.83
EBIT Margin
-0.52%1.99%-0.88%-13.98%-5.27%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.